05 Dec, 2023
Lesaffre, a leading player in yeast, bacteria, and baking ingredients, is significantly bolstering its operations in the United States through a series of capital investments and acquisitions. The company is diversifying its focus beyond its traditional strengths into the burgeoning fields of nutrition, health, and biotechnology.
In a bid to support this expansion, Lesaffre is channeling investments into cutting-edge equipment and robust research and development initiatives. Notably, a significant enhancement comes to the Red Star Yeast, LLC yeast plant in Cedar Rapids, Iowa, where Lesaffre has introduced a 10th fermentor. This move is poised to fortify the company's position in yeast production, meeting the growing demand for Red Star Yeast products.
Further amplifying its commitment to animal nutrition and health, Lesaffre has made strategic investments at the same facility. The addition of a new dryer for Phileo, Lesaffre's specialized business unit catering to animal nutrition and health, underscores the company's dedication to meeting customer demands and advancing innovation in this sector.
Beyond domestic ventures, Lesaffre has strategically acquired capabilities from a Massachusetts-based bioscience company specializing in naturally derived molecules for human health benefits. This acquisition is set to integrate seamlessly into Lesaffre's Institute of Science and Technology, fostering advancements in metabolic engineering, particularly for its subsidiary, Recombia Biosciences. In a noteworthy development, new state-of-the-art laboratories are set to open this month, signaling Lesaffre's commitment to pioneering research and development.
Lesaffre's expansion endeavors are poised to significantly impact its footprint in the United States, creating synergies across various sectors and reinforcing its position as an industry leader.
19 Nov, 2024
06 Nov, 2024
29 Oct, 2024
28 Oct, 2024
18 Oct, 2024
10 Oct, 2024
© 2024 Business International News. All rights reserved | Powered by Cred Matters.